James’ research focuses on understanding the mechanisms of immunotherapy and he has a big interest in biobanking. He is also Chief Investigator for the ARTIST trial.
March 25, 2026
James’ research focuses on understanding the mechanisms of immunotherapy and he has a big interest in biobanking. He is also Chief Investigator for the ARTIST trial.
The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.
